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Abstract
Background: Commonly employed clustering methods for analysis of gene expression data do not directly
incorporate phenotypic data about the samples. Furthermore, clustering of samples with known phenotypes is
typically performed in an informal fashion. The inability of clustering algorithms to incorporate biological data in
the grouping process can limit proper interpretation of the data and its underlying biology.
Results: We present a more formal approach, the modk-prototypes algorithm, for clustering biological samples
based on simultaneously considering microarray gene expression data and classes of known phenotypic variables
such as clinical chemistry evaluations and histopathologic observations. The strategy involves constructing an
objective function with the sum of the squared Euclidean distances for numeric microarray and clinical chemistry
data and simple matching for histopathology categorical values in order to measure dissimilarity of the samples.
Separate weighting terms are used for microarray, clinical chemistry and histopathology measurements to control
the influence of each data domain on the clustering of the samples. The dynamic validity index for numeric data
was modified with a category utility measure for determining the number of clusters in the data sets. A cluster's
prototype, formed from the mean of the values for numeric features and the mode of the categorical values of all
the samples in the group, is representative of the phenotype of the cluster members. The approach is shown to
work well with a simulated mixed data set and two real data examples containing numeric and categorical data
types. One from a heart disease study and another from acetaminophen (an analgesic) exposure in rat liver that
causes centrilobular necrosis.
Conclusion: The modk-prototypes algorithm partitioned the simulated data into clusters with samples in their
respective class group and the heart disease samples into two groups (sick and buff denoting samples having pain
type representative of angina and non-angina respectively) with an accuracy of 79%. This is on par with, or better
than, the assignment accuracy of the heart disease samples by several well-known and successful clustering
algorithms. Following modk-prototypes clustering of the acetaminophen-exposed samples, informative genes
from the cluster prototypes were identified that are descriptive of, and phenotypically anchored to, levels of
necrosis of the centrilobular region of the rat liver. The biological processes cell growth and/or maintenance,
amine metabolism, and stress response were shown to discern between no and moderate levels of
acetaminophen-induced centrilobular necrosis. The use of well-known and traditional measurements directly in
the clustering provides some guarantee that the resulting clusters will be meaningfully interpretable.
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Background
Clustering of biological samples based on microarray
gene expression data is now standard practice in clinical,
biological, toxicological and pharmacological studies [1-
4]. However, there are limitations to various clustering
algorithms. For instance, the classic k-means clustering
algorithm [5,6] uses Euclidean distance to measure dis-
similarity and to cluster objects while the k-modes algo-
rithm [7] only supports categorical or qualitative data
through a simple matching objective function as a meas-
ure of dissimilarity. The inability of clustering algorithms
to incorporate biological data in the grouping process can
limit thorough interpretation of the data and its underly-
ing biology.
Several approaches to incorporate biological data associ-
ated with samples into the analysis of gene expression
data have been proposed recently. Shannon et al. [8] uti-
lized Mantel statistics to correlate gene expression meas-
urements with clinical covariates. The correlations are
based on separate distance matrices computed using gene
expression data and clinical covariates. Pearson correla-
tion is used to assess main effects, whereas partial correla-
tion coefficients are used to assess correlation between
gene expression and a subset of the sample covariates con-
ditioned on other sample covariates. Another approach
introduced by Sese et al. [9] describes an itemset con-
strained clustering method where the optimal cluster that
maximizes the interclass variance of gene expression with
pathological features between groups is computed.
Informative gene expression clusters annotated with dis-
ease descriptions of the liver were revealed. Kasturi and
Acharya [10] proposed a model-free clustering method
called information fusion, which uses SOMs Kohonen
learning to update the weights for clusters and to essen-
tially correlate microarray gene expression patterns with
repeated motifs in the upstream region of genes. A poten-
tial limitation to this approach is that the grid of the nodes
for the SOM has to be defined beforehand and the results
of the clustering are dependent on the geometry of the
grid. The development of additional methods to simulta-
neously cluster samples based on microarray gene expres-
sion data with associated biological information is
reasonably expected to improve the grouping of samples
and to enhance the discovery of biological processes that
are correlated with phenotypic end-points.
Recent work has shown that better inference of genomic
indicators for an outcome is obtained by integrating gene
expression data with clinical or phenotypic data. For
instance, Gevaert et al. [11] demonstrated that partial
integration of clinical measurements with gene expression
data through separate Bayesian networks that are joined
by a single phenotype variable, improved the prediction
of the prognosis of breast cancer. Others have used princi-
pal component analysis with an analysis of variance or
partial least squares to associate gene expression data with
clinical measurements for improved classification or pre-
diction of an outcome [12,13]. In addition, a novel clus-
tering approach that incorporates epigenetic (genes
monitored for hypermethylation according to a binary
[0,1] status) and phenotypic data (clinical measurements
encoded as ordinal categorical variables), was shown to
group tumor samples sufficiently well enough for discov-
ery of informative pathways that adhere to strict heritabil-
ity in breast cancer [14]. The approach, called heritable
clustering, was suggested to be a framework to integrate
other biological data. However, the extension of the algo-
rithm for the analysis of high dimensional gene expres-
sion data integrated with clinical data as continuous
measurements and phenotypic data as categorical values
simultaneously has not been investigated.
Since the k-means and k-modes algorithms are efficient
for processing large numeric and categorical data sets
respectively, the combination of objective functions for
measuring dissimilarity has been applied in the k-proto-
types algorithm as a practical approach to extend the k-
means-like algorithm for clustering large data sets with
categorical values [7]. To test the utility of the k-prototypes
algorithm for clustering samples based on numeric micro-
array gene expression data and clinical chemistry evalua-
tions with histopathological observations as categorical
values, we introduce a modk-prototypes algorithm. The
approach follows the k-means paradigm with randomiza-
tion of initialization of the algorithm and is evaluated ini-
tially using two data sets. A simulated data set and a heart
disease mixed type data set for proof-of-principle. The
strategy involves constructing an objective function from
the sum of the squared Euclidean distances for numeric
data with simple matching for categorical values in order
to measure dissimilarity of the samples. Separate weight-
ing terms are used to control the influence of each data
domain on the clustering of the samples. The dynamic
validity index for numeric data was modified with a cate-
gory utility measure in order to determine the optimal
number of clusters in the mixed type data. A cluster's pro-
totype is formed from the mean of the values for numeric
features and the mode of the categorical values of all the
samples in the group. The cluster's prototype is taken as a
representation of the feature values that depicts the phe-
notype of the samples in the group.
Further rigorous investigation of the modk-prototypes
clustering method is then pursued by applying it to gene
expression data and associated phenotypic evaluations
from acetaminophen-exposed rat liver samples. Acetami-
nophen, which is an analgesic, causes centrilobular necro-
sis in the rat liver at high dose exposures. Using a chi-
square test and GO annotations of selected genes whichBMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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significantly distinguish differences between prototypes
of clusters of the acetaminophen data set across all three
data domains, phenotypic prototypes were obtained
which were descriptive of, and anchored to, necrosis of
the centrilobular region of the rat liver. This is an end-
point manifested from high dose exposures of acetami-
nophen in the rat liver.
Results
Clustering mixed data types
The data sets used for clustering and the components of
the modk-prototypes algorithm are shown in Figure 1a.
The α, β and γ weighting terms influence how much each
data domain contributes to the clustering of the samples.
An objective function with the sum of the squared Eucli-
dean distances for numeric data and simple matching for
categorical values is used to measure the dissimilarity of
the samples. Samples are grouped using k-means cluster-
ing based on numeric attributes and k-modes clustering
for attributes with categorical values. The DVI and CU
measures comprise the DVI_CU score that measures the
validity of the clustering. The modk-prototypes algorithm
is shown in Figure 1b and is a modification of the original
k-prototypes algorithm [15]. For k = 2 to N number of
samples and for B iterations, assignment of each sample is
made to one of the k clusters based on the minimal dis-
tance of the sample to the prototypes of the clusters. The
prototypes are updated and the samples are reassigned
repeatedly until there is no more change in cluster assign-
ment. The DVI_CU score is computed for the final assign-
ment of the samples. The number of clusters in the data is
estimated by finding the assignment of the samples, over
all B initializations and all k partitions, which yielded the
optimal validity score.
Initial validation of the modk-prototypes algorithm was
performed by evaluating the clustering of the samples in
the simulated and the Cleveland Clinic heart disease
mixed data sets. Clustering of the simulated data was per-
formed with adaptive weighting of the numeric and cate-
gorical data. After 50 trial clustering attempts over 2 to k
possible clusters in the data, the modk-prototypes algo-
rithm partitioned the data into 3 clusters with the samples
in their respective class group (i.e., samples #s 12–22, 33–
43 and 44–54 together respectively). Figure S3 in Addi-
tional file 1 illustrates the minimization of the DVI_CU
index at k = 3.
Clustering of the Cleveland Clinic heart disease data was
performed with equal domain weighting. A plot of the
DVI_CU validity measure at all values of k shows a mini-
mum at k = 2, implying that the estimated number of clus-
ters is two (Figure 2a). Additional file 2 shows the
assignment of the samples to either of the two clusters
along with the categorical value for the chest pain type
attribute. Cluster 1 has 169 patient samples grouped
together with pain type of angina suggestive of having
heart disease (sick) while Cluster 2 has 134 patient sam-
ples grouped similarly together with non-angina repre-
sentative of being without heart disease (buff). The
accuracy of the clustering of the patients into the two
groups was 79%. This is on par with, or better than, the
classification accuracy of the samples by the NTGrowth,
C4 and CLASSIT, and conceptual clustering classification
algorithms which were reported to the University of Cali-
fornia at Irvine repository for machine learning as 77%,
74.8% and 78.9% respectively. This analysis indicates that
the modk-prototypes algorithm can effectively cluster
mixed data types leading to relatively accurate assignment
of the samples to clusters with the appropriate clinical
label.
Similarly, application of the modk-prototypes algorithm
with equal domain weighting to the acetaminophen
mixed data indicates a minimum value for the DVI _CU
validity measure at k = 3 (Figure 2b), implying that there
are three clusters in the data. Ten samples were grouped
into Cluster 1, nine into Cluster 2 and 45 into Cluster 3
(Additional file 3). The samples in Cluster 3 are com-
prised mostly of low dosed (50, 150 mg/kg) samples and
high dosed (1500 and 2000 mg/kg) samples at 6 hrs
except for 5 animals (rats #s 405, 406, 423, 518 and 520)
that had low ALT and AST enzyme levels (Additional file
4). Elevated levels of ALT and AST correlate with liver
injury. Cluster 2 contains all samples exposed to a high
dose of acetaminophen for 18 or 24 hrs. Cluster 1 has
samples exposed to high dose of acetaminophen for 48
hrs, except for moderate responder rats #s 407, 416 and
420, that were dosed for 18 or 24 hrs and had moderately
elevated ALT and AST enzyme levels.
Validation of clustering the acetaminophen mixed data
We next assessed the ability of the algorithm to cluster the
samples according to the level of liver necrosis. At toxic
doses of acetaminophen, glutathione is depleted leading
to the formation of a reactive intermediate that covalently
binds to sulfhydryl groups of several cellular proteins
[16]. These adducts are thought to contribute to tissue
necrosis [17]. The indicator variable representing the his-
topathological observations made by board-certified
pathologists on the centrilobular region of the liver was
removed from the data set prior to running the modk-pro-
totypes algorithm. This variable was then used as an exter-
nal indicator to validate the assignment of samples to the
three clusters. This observation has four feature values for
all the exposed samples denoting either no, minimal,
mild, or moderate severity of necrosis of the centrilobular
region of the liver. Using the modk-prototypes algorithm
with k set at 3 and equal weighting of the microarray, clin-
ical chemistry and histopathology domain data, 90% ofBMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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Modified k-prototypes clustering of mixed data types Figure 1
Modified k-prototypes clustering of mixed data types. a) The data sets used for clustering and the components of the modk-
prototypes algorithm. The type of the data is denoted in parentheses. b) The k-prototypes algorithm was modified (termed 
modk-prototypes) to include B iterations of the assignment of the samples to the k number of clusters for each k = 2 to N 
number of samples. d(Xi, Ql) is the dissimilarity function between the ith sample and the lth cluster prototype. The cluster proto-
types are updated and the samples are reassigned repeatedly until there is no more change in cluster assignment. The validity 
score is computed for the final assignment of the samples. The number of clusters in the data is estimated by finding the assign-
ment of the samples (over all B initializations and all k partitions) that yielded the optimal validity score.BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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Determination of k clusters in the heart disease and acetaminophen data sets using modk-prototypes Figure 2
Determination of k clusters in the heart disease and acetaminophen data sets using modk-prototypes. The a) heart disease data 
and b) acetaminophen data were clustered using the modk-prototypes algorithm at values of k increasing from 2 to the N 
number of samples in the data. DVI_CU (on the y axis) was computed and plotted for the clustering of the data at each value 
of k (on the x axis). Only k = 2 to 10 is shown.BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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the cluster assignments of the acetaminophen-treated
samples had an adjusted Rand Index R' value greater than
0.64 when compared to the groups of the samples accord-
ing to the observed level of necrosis (Figure 3). Since there
were three clusters generated in the mixed data, yet four
classes of acetaminophen-exposed centrilobular necrosis
of the liver, perfect agreement was not possible, but the
achieved clustering approached maximal validity given
the external classification (Figures 2b and 3).
Weighting schemes for clustering the acetaminophen 
mixed data
Proposed weighting of the domain data
Differential weighting of the domains may lead to further
improved accuracy of the clustering procedure, as pro-
posed by Lance and Williams [18] who introduced a clus-
tering algorithm dependent on the weight of dissimilarity
between objects [5]. User defined weights for clustering
permit more or less influence to be given to particular
components of the dissimilarity function. Several investi-
gators at the NIEHS/National Center for Toxicogenomics
responded to a survey in which they were asked to pro-
pose weights for clustering the acetaminophen microar-
ray, clinical chemistry and histopathology data sets by
assigning values for the modk-prototypes algorithm
parameters α, β and γ respectively. Their suggestions are
listed in Table 1.
Two respondents, numbers 7 and 8, suggested different
weighting schemes according to whether the end goal of
the clustering of the samples was to either identify
biomarkers related to histopathological changes follow-
ing exposure to a toxicant, or to ascertain biological proc-
esses and pathways related to the phenotype of the
samples. One respondent suggested two weighting
schemes, one which is purported for data containing
microarray, clinical chemistry and histopathology meas-
urements (suggestion 5a) and one for molecular valida-
tion of toxicological evaluations of the samples
(suggestion 5b). Two other respondents, numbers 14 and
15, suggested that the domain data be weighted according
to preferred outcomes in the analysis of the data. The
former proposed (i) equal weighting or (ii) coupling biol-
ogy with phenotype whereas the latter proposed cluster-
ing based on (i) general effects of the treatment, (ii)
specific injury and end-points from the exposure or (iii)
the affected pathways. The averages of the suggested
weights were 0.51, 0.24 and 0.25 for α, β and γ respec-
tively. The standard deviations of the suggested weights
were low (<0.16). However, the standard deviations of the
β and γ weights were less than that of the α weight.
Table 1: Proposed weighting schemes for the domain data.
Expert αβγ
1 0.6 0.2 0.2
2 0.5 0.2 0.3
30 . 5 0 . 2 5 0 . 2 5
4 0 . 600 . 4
5a 0.2 0.5 0.3
5b 0.8 0.1 0.1
6 0.6 0.1 0.3
7a 0.4 0.4 0.2
7b 0.4 0.2 0.4
8a 0.6 0.3 0.1
8b 0.4 0.2 0.4
9 0.6 0.2 0.2
10 0.6 0.2 0.2
11 0.6 0.2 0.2
12 0.4 0.3 0.3
13 0.333 0.333 0.333
14a 0.333 0.333 0.333
14b 0.5 0.2 0.3
15a 0.7 0.2 0.1
15b 0.3 0.4 0.3
15c 0.7 0.2 0.1
Average 0.508 0.239 0.253
Standard Dev. 0.152 0.113 0.100
Validation of the cluster assignments for the acetaminophen  data Figure 3
Validation of the cluster assignments for the acetaminophen 
data. modk-prototypes clustering of the acetaminophen data 
was performed 100 times at k = 3 using equal weighting of 
the microarray, clinical chemistry and histopathology domain 
data. The necrosis of the centrilobular region of the rat liver 
histopathology observation was removed from the data prior 
to clustering and used as an external indicator of cluster 
assignment validation. The adjusted Rand index (x axis) was 
computed for each clustering of the data and graphed by 
count (y axis) of cluster assignments scored with the range of 
the index.
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Simultaneous clustering using domain weights
Table 2 lists the determination of k and validation results
of the simultaneous clustering of the acetaminophen
microarray, clinical chemistry and histopathology data
sets using the modk-prototypes algorithm with specified
weights. Equal weights of the domain data in the cluster-
ing process resulted in k = 3 and R' of 0.64 when the four
centrilobular necrosis of the liver histopathology observa-
tion levels were used as an external indicator of clustering
validity. Adaptive (α, β and γ adjusted to 0.26, 0.39 and
0.35 respectively) or proposed weighting of all three
domain data yielded clustering results with k = 3, but R' =
0.64 or 0.67.
The highest agreement among all weighting schemes
tested was achieved when the clinical chemistry data was
given all of the weight. However, utilizing only the micro-
array data in the clustering process resulted in partitioning
of the samples into just two groups with R' = 0.51. Exclud-
ing the microarray data from the analysis by weighting the
clinical chemistry and the histopathology data equally
yielded three clusters and R' = 0.64. Placing all the weight
on the histopathology data or splitting the weighting
equally between the microarray and histopathology data
resulted in the poorest agreements (R' = 0.33 and 0.46
respectively) of the cluster assignments. Interestingly, hav-
ing the weighting shared between at least the microarray
and clinical chemistry domain data appears to be advan-
tageous for clustering the data irrespective of the balanc-
ing of the weights. Surprisingly, no weighting scheme that
included the histopathology data resulted in cluster
groups with k > 4. However, partitions with k = 6 and k =
5 were obtained respectively, when clinical chemistry data
alone and microarray with clinical chemistry data were
used for clustering the samples. The latter resulted in R' =
0.66. With the weight of the microarray data set > 0.5 and
some weight given to the histopathology data, weighting
schemes for clustering of the biological samples validated
with R' = 0.67 and k = 3 (the estimated number of clusters
in the data [Figure 2b]).
Phenotypic Prototypes
End-point components of the prototypes
The groups of samples from the modk-prototypes algo-
rithm were analyzed next for phenotypic prototypes by
extracting histopathological feature value labels, clinical
chemistry measurements, and genes from the prototypes
of the clusters that (1) distinguish between pathologic
outcomes and (2) best represent the underlying biology of
the data. This analysis was performed on the acetami-
nophen microarray, clinical chemistry and histopathol-
ogy data (including the centrilobular necrosis variable)
with k = 3 and the α, β and γ weights set at 0.51, 0.24 and
0.25, respectively (see Tables 1 and 2 for the averages of
the suggested weights). Table 3 lists partial prototypes of
the resulting Clusters 1, 2, and 3 that represent samples
grouped with moderate, no and mild levels, respectively,
of necrosis of the centrilobular region. Samples in Clusters
1 and 3 were qualified by moderate and mild necrosis. By
contrast, the majority of the samples in Cluster 2 were
either low dosed (50 or 150 mg/kg) at any of the dura-
tions of exposure, or high dosed (1500 and 2000 mg/kg)
for short durations (6 and 18 hrs). Except for 3 altered-
responder rats (#s 423, 520 and 522) that were dosed for
24 or 48 hrs (Table 4). These exposures were expected to
give at least a mild hepatotoxic phenotype. However, the
ALT and AST levels for these animals were far below the
treatment group average for these enzymes (see Addi-
Table 2: Validation of clustering the samples from the acetaminophen data using modk-prototypes.
Weighting Scheme αβγ Adjusted Rand Index k
1 0.333 0.333 0.333 0.64 3
2 100 0 . 5 1 2
3 010 0 . 6 9 6
4 001 0 . 3 3 2
5 0.5 0.5 0 0.66 5
6 0.5 0 0.5 0.46 4
7 0 0.5 0.5 0.64 3
8 0.51 0.24 0.25 0.67 3
9 0.4 0.4 0.2 0.64 3
10 0.4 0.2 0.4 0.67 3
11 0.6 0.2 0.2 0.67 3
12 0.2 0.4 0.4 0.64 3
13* 0.26 0.39 0.35 0.64 3
14 0.8 0.1 0.1 0.67 3
15 0.7 0.15 0.15 0.67 3
α, β and γ denote the weights for the microarray, clinical chemistry and histopathology data domain dissimilarity measures, respectively. k is the 
number of clusters formed.BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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tional file 4). Clusters 1 and 3 contained only high dosed
samples (1500 and 2000 mg/kg) with the durations of
exposure beyond 6 hrs (18, 24 or 48 hrs). In Cluster 3,
most of the samples (6 of 9) were exposed for a time
frame in which partial recovery from the treatment is
expected (namely 48 hrs), whereas Cluster 1 only contains
samples dosed for either 18 or 24 hrs. The samples in
Clusters 1 and 3 also showed markedly and moderately
elevated ALT and AST enzyme levels, as well as moderate
and minimal congestion of the sinusoid region, respec-
tively. Furthermore, the samples from the rats in Cluster 3
were represented by a histopathologic prototype charac-
terized by minimal inflammatory cell infiltration in the
centrilobular region, regeneration and degradation of the
hepatocytes. The latter observed in the left medial lobe
region. Samples from rats #s 407, 416 and 420 were dosed
with 1500 mg/kg acetaminophen for either 18 or 24 hrs
durations, but had only modest elevations of ALT and
AST. Finally, from the prototype, samples in Cluster 1
were observed to have minimal hypertrophy of the hepa-
tocytes predominantly. The rest of the histopathology fea-
ture values for the three clusters were not informative (all
had no observed end-point) and therefore not included as
representative features in the phenotypic prototypes.
Of the clinical chemistry measurements listed in Table 3
for each cluster prototype, ALT and AST levels clearly dis-
tinguish Cluster 1 samples labelled with the prototype
feature as moderate necrosis of the centrilobular region of
the liver from the two other clusters. In addition, elevated
levels of TBA and decreased blood cholesterol differenti-
ate samples in Cluster 1 from samples in Clusters 2 and 3
reasonably well.
Gene expression component of the prototypes
Differences in gene expression levels between each cluster
are shown in Figure 4a. The Cluster 2 prototype labelled
with no necrosis of the centrilobular region had the least
amount of differential gene expression of the samples in
the cluster. Samples in Clusters 1 and 3 with moderate
and mild necrosis of the centrilobular region as represent-
ative indicators respectively, had numerous genes with
over 2-fold differential expression. The most dramatic
gene expression differences were observed in the compar-
ison of no versus moderate (Cluster 2 vs Cluster 1) necro-
sis of the centrilobular region of the liver, while the
moderate versus mild comparison showed only slight dif-
ferences in magnitude of expression between gene expres-
sion prototypes.
To extract genes from the pairwise comparisons of the
expression component of the prototypes for the clusters
that could statistically distinguish between levels of necro-
sis of the centrilobular region of the liver, a chi-square
goodness-of-fit test was employed using the observed dif-
ference in a gene's expression ratios between two proto-
types and the expected gene expression differences of all
pairwise comparisons for all genes in the prototypes. With
α  set at 0.05, 82 genes, including several Cytochrome
P450 genes and heme oxygenase 1, were identified as sig-
nificant and unique in distinguishing contrasts between
different levels of necrosis of the centrilobular region of
the liver (Additional file 5). A subset of the genes is shown
in Table 5. In particular, the GO biological processes cell
growth and/or maintenance, amine metabolism and
stress response discerned between clusters of samples
grouped according to no and moderate necrosis of the
centrilobular region of the rat liver. Mild and moderate
Table 3: Partial end-point components of the phenotypic prototypes from the clustering of the acetaminophen-treated samples.
Cluster
Features 1 2 3
Cong_Sinusoid Moderate None Minimal
Necr_Cent Moderate None Mild
Infl_Cent None None Minimal/Mild*
Hypert_Hepa Minimal None None
Regen_Hepa None None Minimal
Dege_Hepa* None None Minimal
ALB (g/dL) 5.16 5.03 4.78
ALP (IU/L) 413.22 323.43 368.78
ALT (IU/L) 9649.40 118.48 1676.10
AST (IU/L) 20304.00 171.80 2820.20
Creat (mg/dL) 0.70 0.70 0.70
BUN (mg/dL) 23.56 15.56 18.11
CHOLE (mg/dL) 59.78 86.54 85.44
TBA (umol/L) 61.67 7.61 43.56
SDH (IU/L) 2.89 32.41 398.89
TP (g/dL) 7.53 7.52 7.19
* Observed in the left medial lobeBMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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Table 4: Cluster assignment of the acetaminophen-treated samples.
Cluster 1 Cluster 2 Cluster 3
Treatment Animal # Treatment Animal # Treatment Animal #
1500 MG/K18 HR 404 50 MG/KG6 HR 202 1500 MG/K24 HR 407
1500 MG/K24 HR 419 50 MG/KG6 HR 203 1500 MG/K48 HR 411
1500 MG/K24 HR 421 50 MG/KG18 HR 204 1500 MG/K48 HR 412
2000 MG/K18 HR 505 50 MG/KG18 HR 206 1500 MG/K18 HR 416
2000 MG/K18 HR 506 50 MG/KG24 HR 208 1500 MG/K24 HR 420
2000 MG/K24 HR 508 50 MG/KG24 HR 209 1500 MG/K48 HR 424
2000 MG/K24 HR 509 50 MG/KG48 HR 210 2000 MG/K48 HR 510
2000 MG/K18 HR 516 50 MG/KG48 HR 211 2000 MG/K48 HR 512
2000 MG/K24 HR 521 50 MG/KG48 HR 212 2000 MG/K48 HR 524
50 MG/KG6 HR 213
50 MG/KG6 HR 214
50 MG/KG18 HR 216
50 MG/KG18 HR 217
50 MG/KG24 HR 220
50 MG/KG24 HR 221
50 MG/KG48 HR 223
150 MG/KG6 HR 302
150 MG/KG6 HR 303
150 MG/KG18 HR 306
150 MG/KG24 HR 307
150 MG/KG24 HR 308
150 MG/KG48 HR 310
150 MG/KG48 HR 311
150 MG/KG48 HR 312
150 MG/KG6 HR 314
150 MG/KG6 HR 315
150 MG/KG18 HR 316
150 MG/KG18 HR 317
150 MG/KG18 HR 318
150 MG/KG24 HR 319
150 MG/KG24 HR 320
150 MG/KG48 HR 324
1500 MG/K6 HR 402
1500 MG/K6 HR 403
1500 MG/K18 HR 405
1500 MG/K18 HR 406
1500 MG/K6 HR 413
1500 MG/K6 HR 414
1500 MG/K48 HR 423
2000 MG/K6 HR 501
2000 MG/K6 HR 503
2000 MG/K6 HR 513
2000 MG/K6 HR 514
2000 MG/K18 HR 518
2000 MG/K24 HR 520
2000 MG/K48 HR 522BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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Gene expression components of the phenotypic prototypes Figure 4
Gene expression components of the phenotypic prototypes. Plotting of the gene expression component of the prototypes 
from the clusters generated from clustering the acetaminophen data using the modk-prototypes algorithm (with the levels of 
the necrosis of the centrilobular region of the rat liver included, 100 iterations and the average of the suggested weights of the 
domain data). a) All genes detected as significantly differentially expressed b) 82 genes significant and unique in distinguishing 
contrasts between the levels of necrosis of the centrilobular region of the rat liver. The red, blue and green lines denote the 
gene expression prototype from Clusters 1, 2 and 3 respectively. The log10 ratio values of the genes from the prototypes are 
signified on the y axis and the indices for the genes are denoted on the x axis.BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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Table 5: Subset of significant and unique genes that distinguish between levels of centrilobular necrosis of the rat liver.
Cluster Comparison
Feature ID Gene Description A vs B
A_42_P464546 AI501407 TNFAIP3 interacting protein 2 1 2
A_42_P496622 AI232716 Similar to thioether S-methyltransferase 1 2
A_42_P552441 BI303289 Growth arrest specific 5 1 2
A_42_P565917 BF392498 Cytochrome P450, family 2, subfamily u, polypeptide 1 1 2
A_42_P681012 NM_013055 Mitogen activated protein kinase kinase kinase 12 1 2
A_42_P684538 NM_138827 Solute carrier family 2 (facilitated glucose transporter), member 1 1 2
A_42_P767698 BE097112 EBNA1 binding protein 2 1 2
A_42_P786624 NM_012693 Cytochrome P450, subfamily 2A, polypeptide 1 1 2
A_42_P788480 BF419374 Thyrotroph embryonic factor 1 2
A_43_P11472 NM_012580 Heme oxygenase (decycling) 1 1 2
A_43_P11681 NM_013048 Tocopherol (alpha) transfer protein 1 2
A_43_P12400 NM_024134 DNA-damage inducible transcript 3 1 2
A_43_P12595 NM_031576 P450 (cytochrome) oxidoreductase 1 2
A_43_P12996 NM_053955 Crystallin, mu 12
A_42_P487744 BF396233 Similar to 2410004L22Rik protein 1 3
A_42_P607568 AI176590 Similar to RIKEN cDNA C730048E16 1 3
A_42_P634040 AW918024 Ngg1 interacting factor 3-like 1 (S. pombe) 1 3
A_42_P634187 AW252746 Forkhead box D4 13
A_42_P677628 NM_031642 Core promoter element binding protein 1 3
A_42_P681533 AI237597 Transcribed locus, moderately similar to NP_034610.1 heat shock protein 1, alpha [Mus 
musculus]
13
A_43_P11142 Y10056 S100 calcium binding protein A11 (calizzarin) (predicted) 1 3
A_43_P11477 NM_012591 Interferon regulatory factor 1 1 3
A_43_P12806 NM_053439 RAN, member RAS oncogene family 1 3
A_43_P14163 NM_012615 Ornithine decarboxylase 1 1 3
A_43_P14782 AI406490 Tyrosine kinase, non-receptor, 2 1 3
A_43_P16550 CA509226 Splicing factor 3a, subunit 1 (predicted) 1 3
A_43_P19988 CB545293 Similar to CGI-94 protein (predicted) 1 3
A_42_P539275 AA891212 Replication factor C (activator 1) 3 2 3
A_42_P660046 BF551617 Kinesin family member 16B (predicted) 2 3
A_42_P780457 AI071307 Ectodermal-neural cortex 1 2 3
A_43_P11285 BQ209715 Similar to Cc2-27 (predicted) 2 3
A_43_P20438 CB545761 Small optic lobes homolog (Drosophila) (predicted) 2 3BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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centrilobular necrosis appeared to involve amine metabo-
lism.
A clearer picture of the differences between the samples in
the clusters labelled with either no, mild or moderate
necrosis of the centrilobular region of the rat liver was
obtained by comparisons of Clusters 1, 2 and 3 using just
the expression values of the 82 genes extracted from the
prototypes (Figure 4b). About 75% of the genes progres-
sively increase or decrease in differential expression as the
level of necrosis of the centrilobular region of the liver
transitions from no to mild to moderate. Finally, hierar-
chical clustering of the biological samples reveals very
good grouping of the low dosed and high dosed samples.
The latter very prominent and tight within time groups
(Figure 5). Interestingly, as shown in Figure 6, the nine
no- or moderately-responding rats (#s 405, 406, 407, 416,
420, 423, 518, 520 and 522) were distinctly different from
their counterpart dose-by-time group subjects in terms of
ALT enzyme levels. The high dosed 6 hrs rats differed from
the high dosed 18, 24 and 48 hrs rats by a small cluster of
genes that include an activator (Mitogen activated protein
kinase kinase kinase 12 [Map3k12]) of the c-Jun N-termi-
nal kinase (JNK) pathway, a transactivator of thyroid-
stimulating hormone beta, and a regulator of neuronal
differentiation and development.
Discussion
Clustering of microarray gene expression data has
matured by virtue of the growing number of analytical
approaches for partitioning data. k-means is one of the
most widely used unsupervised clustering methods for
gene expression data. Unfortunately, k-means clustering,
and other approaches such as SOMs do not guarantee glo-
bally optimal partitioning, require specifying the number
of clusters or the configuration of the underlying classifi-
cation structure, and suffer from inflexibility with respect
to incorporation of associated biological data. More
importantly, most clustering algorithms support only
quantitative or qualitative data but not both simultane-
ously. Huang [15] introduced the k-prototypes algorithm
that utilizes the clustering objective function of k-means
for numeric measurements and k-modes for categorical
values to partition data. We have proposed modifying this
algorithm by adding an objective function to support and
weight multi-domain, mixed type biological data within
the k-means clustering paradigm. The advantage of our
modk-prototypes algorithm is that simultaneous cluster-
ing of gene expression data with clinical chemistry evalu-
ations and histopathology observations results in
informative clusters that are formed with prototypes of
genes and values from end-point variables that are
anchored to the phenotypes of samples with similar bio-
logical outcomes.
Our method is one of a class of approaches that seek to
incorporate biological data directly into the clustering
process [9,14]. Using necrosis of the centrilobular region
of the rat liver following acetaminophen exposure as an
end-point to couple with gene expression profiles, clinical
chemistry evaluations and histopathological observa-
tions, simultaneous clustering of the data with the modk-
prototypes algorithm revealed phenotypic prototypes
which were capable of distinguishing between no, mild
and moderate levels of necrosis of the liver (Tables 3 to 5;
Figure 4). For instance, non- or moderately-responding
rats to acetaminophen exposure were distinctly different
from their counterpart dose-by-time group subjects. Fur-
thermore, the high dosed 6 hrs rats vs the high dosed 18,
24 and 48 hrs rats differed by a small cluster of genes
involved in signal transduction and growth regulation.
Not surprisingly, Cytochrome P450 genes and heme oxy-
genase 1, which have functions in detoxification and
redox regulation in response to oxidative stress, were
found to be indicators of toxicity in the gene expression
component of the phenotypic prototypes that differenti-
ated between levels of necrosis of the centrilobular region
of the rat liver (Table 5). Several published reports of gene
expression data generated from treatment of biological
samples with toxic agents describe the altered expression
of genes such as these in well-known biological pathways
that are perturbed subsequent to incipient toxicity [19-
24].
Weighting of the terms in the modk-prototypes algorithm
offers the flexibility to balance the influence of each
domain of the data while simultaneously clustering the
mixed data (see equation 1). This is advantageous for
semi-supervised clustering when different goals for ana-
lyzing the data are in mind. The interest might be to clus-
ter biological samples based on gene expression data with
clinical chemistry measurements and histopathology
observations for the purpose of finding biomarkers
related to histopathological changes, or identifying which
biological processes and pathways are related to the phe-
notypic end-point. From empirical analysis of acetami-
nophen-treated rat liver sample data using adaptive
weighting or different weighting schemes, giving some
weight to histopathology observations and at least half of
the weight to the microarray data set is advantageous to
clustering the data (Table 2). Interestingly, although
applying all the weight to the clinical chemistry data gave
the best fit between cluster assignment and histopathol-
ogy evaluation of centrilobular necrosis, the number of
clusters in the data was overestimated. This indicates that
improper weighting of the domain data can potentially
bias the clustering of the samples. Further work is being
done to weight the domain data heuristically.BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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Hierarchical clustering of the biological samples Figure 5
Hierarchical clustering of the biological samples. Log10 transformed gene expression ratio values of the 82 genes from the pro-
totypes of the clusters of the biological samples were subjected to agglomerative hierarchical clustering using cosine correla-
tion as the similarity measure and average linkage methodology. The branches of the dendrograms represent the amount of 
similarity between clusters of samples.BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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The high dimensionality of data has challenged the effi-
ciency and reliability of clustering algorithms for quite
sometime. In high dimensional space, data points
become sparse making the use of some distance measures
meaningless. However, results from experiments on real-
world high dimensional data have shown that distance
measures based on the Minkowski Ld metrics, where d is
either 1 or 2, increases or remains constant as the dimen-
sionality of the data increases [25]. Our modk-prototypes
algorithm is based on the Euclidean (L2) distance metric
for the high dimensional microarray data and clinical
chemistry data. Given the aforementioned theoretical
work plus our own simulation of a smaller scaled data set
and reduction of the high dimensional numeric data (see
Additional file 1), we are convinced that the clustering of
the samples using the modk-prototypes algorithm is not
dependent on the scale or dimensionality of the data. The
simulation results also provide evidence that the algo-
rithm is at least able to find a small number of true/known
clusters when they exist. Furthermore, the phenotypically
anchored genes that were acquired from the prototypes of
the clusters from the acetaminophen-exposed samples
suggest that the modk-prototypes algorithm forms groups
of samples that are biologically meaningful. Additional
Two-way hierarchical clustering of the biological samples and the extracted genes Figure 6
Two-way hierarchical clustering of the biological samples and the extracted genes. Log10 transformed gene expression ratio val-
ues of the 82 genes from the prototypes of the clusters of the biological samples were subjected to agglomerative hierarchical 
clustering as detailed in Figure 5. The resulting gene expression heat map contains the genes as the rows and samples as the 
columns with red indicating up regulation, green denoting down regulation and black signifying no change. At the top of the 
heat map, the level (UI/L) of ALT is plotted for each sample. At the bottom of the heat map, the severity of centrilobular 
necrosis observed is shown for each sample. (yellow, none; blue, minimal; magenta, mild; green, moderate).BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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applications of the method to a variety of simulated and
real data sets are underway. These should also help in
determining its usefulness over a range of scales and data
dimensions.
As more biological data becomes available, sophisticated
methods for clustering integrated data will be necessary in
order to glean more meaningful information about the
underlying biology of the samples. Efforts such as integra-
tive genomics, systems biology, toxicogenomics, pharma-
cogenomics and biomedical informatics are generating
volumes of biological data and information spanning
transcriptomics, proteomics, metabolomics, toxicology,
pharmacology, clinical biology and genetics to leverage
each domain data for a more informed assessment of bio-
logical outcomes [12,26-30]. Case in point, the work of
Baskin et al. [31] to collectively analyze microarray, clini-
cal data and pathology observations revealed that gene
expression patterns were very much consistent with the
clinical outcomes, gross pathology and histopathology
from influenza virus-infected pigtailed macaques pri-
mates. However, the identified clusters may not contain
genes that are directly associated with the appearance of
clinical signs or pathological indications of tissue infec-
tion because the domains of data were analyzed inde-
pendently.
The modk-prototypes algorithm is well-suited as a cluster-
ing method for grouping biological samples constrained
by integrated data and feature values. It yields representa-
tives of the clusters (the prototypes) which can potentially
provide an initial insight to the biological mechanism
driving the similarities of the samples and the phenotypes
associated with gene expression. This concept of pheno-
typic anchoring has been proposed and tested as a means
to link the cause of a disease or response with gene expres-
sion patterns and the altered biological processes that fol-
low the observed effect [32-34]. We propose that the
modk-prototypes clustering method will provide a feasi-
ble computational alternative to embark on bridging
multi-domain data analysis frameworks for integrative
genomics, systems biology, pharmacology and toxicol-
ogy.
Conclusion
Many existing methods for clustering gene expression data
do not incorporate phenotypic data about the samples.
We developed the modk-prototypes algorithm using an
objective function with the sum of the squared Euclidean
distances and simple matching for clustering biological
samples based on numeric data and categorical values
respectively. It is a formal approach to cluster gene expres-
sion data with phenotypic data. The algorithm is based on
the original k-prototypes algorithm but is adapted along
the k-means paradigm, it contains weighting terms for
microarray, clinical and histopathology data, and is
designed to determine the number of clusters in the data
by minimizing a DVI_CU measure over all possible num-
bers of clusters and randomization of the initialization of
the algorithm.
The advantage of simultaneous clustering of gene expres-
sion data with clinical chemistry evaluations and histopa-
thology observations is that informative clusters are
formed with prototypes of genes and end-point features
that are linked to the phenotypes of samples with similar
biological outcomes. Following modk-prototypes cluster-
ing of the acetaminophen data with weighting of the
domain data, informative genes from the cluster proto-
types were identified that are descriptive of, and pheno-
typically anchored to, levels of necrosis of the
centrilobular region of the rat liver. From empirical anal-
ysis of acetaminophen-treated rat liver sample data using
adaptive weighting or different weighting schemes, hav-
ing some weight given to the histopathology observations
and weight of the microarray data set > 0.5, are advanta-
geous to clustering the samples. Clustering the mixed data
types in this fashion was better than typical k-means style
clustering of either microarray or clinical chemistry
numeric data alone (i.e. the other data sets weights set at
0) and better than k-modes clustering of the samples
based solely on the histopathology data. We found that
the expression profiles of several Cytochrome P450 genes
and heme oxygenase 1 were significant in their differenti-
ation between levels of centrilobular necrosis of the rat
liver. Cytochrome P450 genes are in high proportion in
the liver and produce detoxification enzymes to metabo-
lize toxicants. Furthermore, the high dosed 6 hrs rats vs
the high dosed 18, 24 and 48 hrs rats differed by a small
cluster of genes containing an activator of the c-Jun N-ter-
minal kinase pathway, a transactivator of thyroid-stimu-
lating hormone beta and a regulator of neuronal
differentiation and development. But overall, cell growth
and/or maintenance, amine metabolism and stress
response were biological processes that discerned between
no and moderate levels of acetaminophen-induced necro-
sis of the centrilobular region of the rat liver. The use of
well-known and traditional measurements directly in the
clustering process provides some guarantee that the result-
ing clusters will be meaningfully interpretable. However,
we realize that improper weights for the domain data can
bias the clustering of the samples. In future work, we will
investigate weighting the domain data heuristically.
Methods
Heart disease mixed data
Heart disease data from the Cleveland Clinic heart disease
database maintained at the University of California at
Irvine repository for machine learning was used as a data
set with mixed features to evaluate the ability of the clus-BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
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tering algorithm to group samples based on mixed data
types. The data set consists of 303 patients defined by 13
clinical features, five of which are numeric and eight cate-
gorical or nominal. The data has two classes: 165 individ-
uals with no heart disease (buff) and 138 individuals with
heart disease (sick).
Acetaminophen microarray gene expression data and 
analysis
Microarray gene expression data was derived from left
liver lobe mRNA samples collected from 4 male Fischer
F344/N rats per dose group exposed to either 50 mg/kg,
150 mg/kg (low doses), 1500 mg/kg or 2000 mg/kg (high
doses) body weight acetaminophen during a light period
(between 12 noon and 1 pm) as well as liver mRNA col-
lected from control (vehicle-treated) male rats [35]. Ani-
mals were sacrificed and mRNA extracted from liver
specimens 6, 18, 24, or 48 hrs after treatment. Each RNA
sample from a treated animal was compared with a pool
of time-matched control mRNAs and analyzed in dupli-
cate (dye reversal experiments) on Agilent-011868
(G4130A) rat oligonucleotide microarrays (Agilent Tech-
nologies, Palo Alto, CA). Acetaminophen exposure to the
rat liver at 50 and 150 mg/kg is subtoxic. However, 1500
and 2000 mg/kg doses induce severe toxicity which peaks
24 hrs after exposure but the rats show signs of recovery
48 hrs after exposure.
Scanning of the microarray chips and acquisition of data
from scanned images were as previously described [22].
Briefly, background subtracted pixel intensity values were
log transformed, normalized and assessed for significance
of expression (p-value < 0.05, Bonferroni corrected) using
an ANOVA model comparing treated samples with time-
matched controls. The approximately 3100 significant
genes' pixel intensity ratio values from dye reversal
hybridizations were combined (same subjects only) using
Rosetta Resolver version 5.1.0.1.23 (Rosetta Biosoftware,
Seattle, WA) error model weighted averaging [36,37]. Two
gene features (A_43_P22641 and A_43_P22629), which
had all values missing, were removed from analysis. The
data used for clustering is in Additional file 6.
Acetaminophen histopathology observations and clinical 
chemistry evaluations
48 histopathological observations of the acetaminophen-
treated rat liver specimen slides and 10 clinical chemistry
measurements on biosamples from the treated animals
were collected as previously described [35]. Observations
include: inflammatory cell infiltration of the centrilobular
region or region not otherwise specified, necrosis of the
centrilobular region or of hepatocytes, hyperplasia of the
centrilobular hepatocytes, glycogen depletion, degenera-
tion or regeneration of the hepatocytes or the centrilobu-
lar region, congestion or glycogen depletion of the
centrilobular region or sinusoid and hyperplasia of the
bile duct. Microscopic qualifiers were categorized as no,
minimal, mild, moderate or marked. Discrepancies in his-
topathology observations were resolved by a team of
board-certified pathologists [38].
Clinical chemistry evaluations of serum samples were per-
formed using a Roche Cobas Fara chemistry analyzer
(Roche Diagnostic Systems, Westwood, NJ) to numeri-
cally measure serum enzyme levels. These included indi-
cators of liver injury (Alanine Aminotransferase [ALT] and
Aspartate aminotransferase [AST]), Sorbitol dehydroge-
nase [SDH], cholesterol levels, indication of renal injury
(urea nitrogen [BUN]), assessment of cholestasis – bile
flow interruption (total bile acids [TBA], Creatine [Creat],
Alkaline Phosphatase [ALP]), total protein (TP) and albu-
min (ALB) levels. Elevated levels of ALT and AST correlate
with liver injury [39]. Missing values were imputed for rats
#s 308 and 309 with either the group average or the over-
all mean value for each evaluation.
Simulation of data for clustering using the modk-
prototypes algorithm
Numeric data
A data set comprised of numeric data with 64 features and
33 objects was simulated from three distinct probability
distributions. Normal deviates (mean 0 and standard
deviation 20) were drawn at random from the 3 probabil-
ity distributions generating 11 objects in each. Samples
that belong to the same class are #s12–22, 33–43, and 44–
54 respectively.
Categorical data
A data set comprised of categorical data with 10 features
and 33 objects was simulated from an HMM using R code
in the HMM discrete non-parametric package. The HMM
contained 3 states modelled on levels of toxicity (no/low,
moderate and severe) and 5 severity levels (none, mini-
mal, mild, moderate and marked) of centrilobular necro-
sis observed in rat livers exposed to acetaminophen. An
independent cDNA microarray gene expression data set
[22] acquired from rat liver samples exposed to 50, 150,
1500 and 2000 mg/kg of acetaminophen for 6, 24 and 48
hrs was used to estimate transition probabilities from a set
of ~700 differentially expressed genes as well as a set of
700 genes selected at random. A third set of transition
probabilities were manually created with a high probabil-
ity (p >= 0.6) of visiting or remaining in the no/low toxic-
ity state. An illustration of the HMM, a curve of the log-
likelihood from the training, the transition and emission
probabilities are in the supplemental materials (Addi-
tional file 1).BMC Systems Biology 2007, 1:15 http://www.biomedcentral.com/1752-0509/1/15
Page 17 of 20
(page number not for citation purposes)
A mixed data set (Additional file 7) was created from the
merge of the numeric and the categorical simulated data
sets.
Modified k (modk)-prototypes algorithm
The Huang [15]k-prototypes algorithm which combines
the k-means and the k-modes objective functions for clus-
tering numeric data and categorical values respectively,
was modified to follow the k-means algorithm paradigm,
and was also optimized to search for clusters formed clos-
est to the global minima of the objective function. In
addition, a separate numeric objective function was uti-
lized for the microarray and the clinical chemistry data
resulting in the following modk-prototypes objective
function:
where Xi is the ith sample, for i = 1 to N number of sam-
ples, Ql is the lth prototype, for l = 1 to k number of clus-
ters, mr is the number of microarray numeric attributes, ms
is the number of clinical chemistry numeric attributes, mc
is the number of histopathological categorical attributes,
α, β and γ denote the weights (W) for the microarray, clin-
ical chemistry and histopathology data domain dissimi-
larity measures, respectively. The weights for data domain
d at the nth step (Wd [n]) are adapted (for controlling how
much each data domain contributes to the clustering of
the samples) as follows:
where tau (τ) is the exponential weighting update factor in
the range [0,1] and avecorr(Xd, Qd) is the average correla-
tion coefficient (Pearson for numeric data, Jaccard for cat-
egorical data) between the samples and the prototypes
based on the feature values from domain d.
where cov is the sample covariance, s is the sample stand-
ard deviation, N  is the number of samples, p  is the
number of features that match and q is the number of fea-
tures that do not match. The value of τ was set to 0.05 in
order to adjust the weight of each domain by 5% at each
iteration. The weights are non-negative and their sum is
constrained to equal 1. The weights could potentially go
to the boundaries [0,1] depending on the data. However,
they can easily be constrained to always be above some
lower bound, e.g. 0.05, or even fixed at proportions that
are appropriate or reasonable to a domain expert.
Letting z represent r for microarray numeric data or s for
clinical chemistry numeric data, the distance between 
and   containing missing values is defined as:
Then the distance between   and   is:
where  d  is the Euclidean distance, p  is the number of
numeric features and p0 is the number of numeric features
with missing values in   and   or both.
For categorical (c) feature values, the dissimilarity meas-
ure between   and   is defined by the total number of
mismatches of the corresponding histopathologic features
from the sample and the prototype   and   respec-
tively such that
where
For B (typically set to 100) times, the modk-prototypes
algorithm initialization is seeded by the domain data vec-
tor of a randomly selected sample for each of the k clus-
ters. For adaptive clustering, recursion was used to update
the prototypes in order to find the configuration of the
initial k-prototypes which ultimately results in the reduc-
tion of the objective function closest to the global mini-
mum. Matlab code and a stand-alone executable program
for the modk-prototypes algorithm to simultaneously
cluster gene expression data with clinical chemistry and
pathological evaluations are available [48].
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Determination of cluster number (k) and validation of 
cluster assignment
To determine the number of clusters in a data set, the DVI
of Shen et al. [40] was used. The DVI is based on an intra/
inter ratio validity index that also includes scaling of the
intra- and the inter-cluster distances.
where
k is the number of clusters, N is the number of samples
and intra is the average Euclidean distance between sam-
ples and the prototype Q of the cluster each sample is
assigned to.
For mixed data with numeric and categorical values, the
DVI was modified to include a CU measure [41] that
defines the probability of matching a categorical feature
value given a cluster versus the probability of the categor-
ical feature value given the entire data set
where P(Ai = Vij) is the unconditional probability of fea-
ture Ai taking on the value Vij, P(Ai = Vij | Ck) is the condi-
tional probability of Ai = Vij given cluster Ck, and k is the
cluster number from 1 to m. The DVI modified with CU
DVI_CU = (DVI + 1/CU)   (8)
is minimized over all k sets for each run of the modk-pro-
totypes clustering algorithm. Validation of cluster assign-
ment was carried out using R', the adjusted Rand index
[42-44]. When two partitions agree totally, R' is 1 and
when the partitions are selected by chance, R' is 0.
Generation of phenotypic prototypes
A cluster's prototype is formed from the mean of the val-
ues for numeric features and the mode of the categorical
values of all the samples in the group. Hence, the cluster's
prototype is taken as a representation of the feature values
that depicts the phenotype of the samples in the group.
The process for obtaining phenotypic prototypes is to
extract all the histopathologic feature value labels and
clinical chemistry measurements as well as significant
genes from the prototypes of the clusters that can distin-
guish between pathological outcomes and best represent
the underlying biology of the group of samples. Let the
observed difference between the expression ratio of the
gth gene (p in total) from the gene expression component
of prototype q for ith and jth (i not equal to j) cluster (k in
total) be observedg = (qgi - qgj) and the expected change in
expression be
Averaging over all the genes gives an estimate of the
expected difference between a gene's ratio values in the
prototypes of two clusters being compared. Assuming
independence and an approximately normal distribution
of differences, genes which have expression ratios which
significantly distinguish between prototypes of clusters
are evaluated using a standard chi-square (X2) goodness-
of-fit test [45]:
where the null hypothesis is that the expression value of
the gth gene does not distinguish between prototypes of a
pair of clusters that are compared. The null hypothesis is
rejected at a level of α, the probability of a type I error, if
 ≥ χ2(1, α) where χ2(1, α) is the α-level critical value of
a χ2-distribution with 1 degree of freedom. An α of 0.05
gives reliable results. Genes from a comparison of two
prototypes which significantly distinguish the clusters are
annotated for biological function and process(es) using
the GO database [46,47].
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